Abstract
Myelodysplastic syndromes (MDS) are a challenging group of diseases for clinicians and researchers, as both disease course and pathobiology are highly heterogeneous. In (suspected) MDS patients, multi-parameter flow cytometry can aid in establishing diagnosis, risk stratification and choice of therapy. This review addresses the developments and future directions of multi-parameter flow cytometry scores in MDS. Additionally, we propose an integrated diagnostic algorithm for suspected MDS.
Original language | English |
---|---|
Pages (from-to) | 14-23 |
Number of pages | 10 |
Journal | Pathobiology |
Volume | 86 |
Issue number | 1 |
Early online date | 2018 |
DOIs | |
Publication status | Published - 1 Jan 2019 |
Keywords
- Diagnosis
- Flow cytometry
- Myelodysplastic syndromes